MidWest Drug Development Conference
Downtown Capitol District, Omaha, Neb. | Oct. 4-5, 2021
2021-10-04 08:00:00
Register!
Downloads
  • Map & Other Info (Coming soon!)
  • Brochure (Coming soon!)
  • Flyer (Coming soon!)
  • 2021 Program (Coming soon!)
  • 2019 Program
  • 2018 Program
  • Home
  • Schedule
  • Venue
  • Technologies
    • Technologies
    • Institutions
    • Startups
    • Previous Technologies
  • Sponsors
  • News
  • Contact
  • Home
  • Schedule
  • Venue
  • Technologies
    • Technologies
    • Institutions
    • Startups
    • Previous Technologies
  • Sponsors
  • News
  • Contact

List is tentative, and subject to change at any time.

SEARCH:

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
ColoradoColorado

University of Colorado Anschutz Medical Campus

Technologies coming soon!

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
Kansas State

Kansas State University

Technologies coming soon!

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
MayoClinic

Mayo Clinic

Technologies coming soon!

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
Ohio State

Ohio State University

Mps1/TTK kinase inhibitor to treat hematological malignancies

Ohio State University

The TTK kinase is critical for proper function of the spindle assembly checkpoint, and its upregulation is associated with poor clinical outcomes in a variety of cancer types.

Read more

Selective estrogen receptor modulator (ER-Beta Agonist) targets cancer

Ohio State University

The estrogen receptors, alpha and beta, are both responsive to endogenous estrogen, but modulate different biological processes.

Read more

DHODH inhibitors to treat hematological malignancies

Ohio State University

Dihydroorotate dehydrogenase (DHODH) is a key enzyme in the de novo pyrimidine synthesis pathway.

Read more

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
PurduePurdue

Purdue University

Antimicrobial Peptides Targeting Intracellular Bacteria

Purdue University

Researchers at Purdue University developed antimicrobial agents against intracellular human pathogens with improved efficacy compared to the group’s previous-generation compounds.

Read more

Therapeutic targets metastatic prostate cancer

Purdue University

Researchers at Purdue University have developed a targeted therapeutic option for treating metastatic prostate cancer, the second leading cause of cancer death for men in the United States.

Read more

Treat glioblastoma with multi-functional natural killer cells and small molecule autophagy inhibitor

Purdue University

Researchers at Purdue University have developed an immunotherapy approach combining cell therapy and a small molecule inhibitor to treat glioblastoma.

Read more

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
ColoradoColorado

University of Colorado-Boulder

Prevent, alleviate side effects of radiation or radiotherapy

University of Colorado-Boulder

Using C. elegans as an animal model to study radiation-induced bystander effects (RIBE), researchers at the University of Colorado Boulder have identified a highly conserved cysteine protease, cathepsin B, as the first RIBE factor.

Read more

Novel selective HDAC6 inhibitors show promise for cancer and beyond

University of Colorado-Boulder

The researchers of the University of Colorado developed a series of hydroxamic acid derivatives as HDAC6 selective inhibitors.

Read more

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
IowaIowaIowa

University of Iowa

Nanoparticle vaccine fights respiratory syncytial virus

University of Iowa

Inventors at the University of Iowa have developed a respiratory syncytial virus vaccine. It is a nanovaccine consisting of viral proteins encapsulated by biodegradable polyanhydride polymers.

Read more

Pristimerin-loaded nanoparticles enhance anti-neoplastic activity of platinum compounds

University of Iowa

Endometrial cancer is the most frequent gynecological cancer and is often treated using platinum-based therapies such as cisplatin.

Read more

Non-viral formulation delivers lubricin genes

University of Iowa

Post-traumatic osteoarthritis weakens the regulation of lubricin gene and increases shear stress within the joints.

Read more

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
KansasKansas

University of Kansas

Technologies coming soon!

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
KentuckyKentucky

University of Kentucky

Technologies coming soon!

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
KentuckyKentucky

University of Minnesota

Humanized antibodies to treat diabetes, range of tissue injuries

University of Minnesota

SerpinB13 is a protease inhibitor linked to autoimmune inflammation and Type 1 diabetes (T1D).

Read more

Agmatine-based pain treatment avoids opioid addiction

University of Minnesota

The search for better analgesics has focused on non-addictive alternatives. Agmatine, the decarboxylated product of arginine, is a potential candidate for novel therapeutics.

Read more

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
MissouriMissouri

University of Missouri

Dual-biomarker targeting agent helps diagnose, treat prostate cancer

University of Missouri

A dual diagnostic and therapeutic compound binds GRPr and PSMA with high specificity and sensitivity.

Read more

Gene therapy improved with new AAV hybrid vector system

University of Missouri

Novel dual- and tri-AAV hybrid vector systems increase the upper size limit of gene constructs from <5kb to <15kb.

Read more

Novel antibiotics target beta-lactamase

University of Missouri

Researchers at the University of Missouri have developed novel inhibitors of beta-lactamase, a bacterial enzyme that provides resistance to β-lactam antibiotics.

Read more

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
NebraskaNebraska

University of Nebraska Medical Center

Technologies coming soon!

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
OklahomaOklahoma

University of Oklahoma

Antitoxin peptides inhibit clostridium difficile

University of Oklahoma

Researchers at the University of Oklahoma have discovered a class of antitoxin peptides that inhibit a critical clostridium difficile virulence factor.

Read more

Persephacin excels as broad-spectrum antifungal

University of Oklahoma

Persephacin, a novel fungal isolate, strongly inhibits a broad range of pathogenic fungi while exhibiting low cytotoxicity to mammalian cells.

Read more

Peptides inhibit Alzheimer’s disease

University of Oklahoma

Bioactive synthetic peptides derived from neutrophil proteins, cathepsin G and CAP37, can inhibit and reverse the formation of toxic amyloid beta aggregates.

Read more

Universities

Colorado Anschutz Medical Campus Purdue University University of Kansas University of Oklahoma
Kansas State University University of Colorado-Boulder University of Minnesota University of Wisconsin
Mayo Research and Education University of Iowa University of Missouri
Ohio State University University of Kentucky University of Nebraska Med Center
WisconsinWisconsin

University of Wisconsin

Nanoparticles deliver bioactive molecules

University of Wisconsin (WARF)

A new hybrid nanocapsule uses a silica, metal and organic framework designed to deliver protein, nucleic acid or hydrophilic drugs.

Read more

Paclitaxel prodrug enhances anticancer efficacy

University of Wisconsin (WARF)

A new formulation of paclitaxel fuses the drug to an oligo-lactic acid (oLA) encapsulated in a PEG-PLA micelle.

Read more

New treatment for Status Epilepticus ‘starves’ problematic neurons

University of Wisconsin (WARF)

This technology uses 2-deoxy-D-glucose (2DG) as a novel treatment for Status Epilepticus (SE).

Read more

Logo

MIDWEST DRUG DEVELOPMENT CONFERENCE
Bringing together industry and the best university drug development researchers in the Midwest
Downtown Capitol District, Omaha, NE
Oct. 4-5, 2021

Latest News
  • Registrations are now open for 2021 March 25, 2021
  • Planners set initial slate of participants, more to come February 22, 2021
  • MidWest Drug Development Conference plans to return in 2021 January 11, 2021
  • MidWest Drug Development Conference for 2020 is postponed July 15, 2020
Twitter Hightlights
  • 👀 https://t.co/WWaZ16hOhr https://t.co/XErdmyAequ
    5 days ago
  • RT @SharpIdeaHub: Drive change in the world with your research - Attend ABC of #SBIR/#STTR #Funding on April 21 at 8:30 am CST Register: ht…
    6 days ago